Phibro Animal Health Corporation (PAHC) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.058x

Based on the latest financial reports, Phibro Animal Health Corporation (PAHC) has a cash flow conversion efficiency ratio of 0.058x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($19.35 Million) by net assets ($332.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Phibro Animal Health Corporation - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Phibro Animal Health Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Phibro Animal Health Corporation for a breakdown of total debt and financial obligations.

Phibro Animal Health Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phibro Animal Health Corporation ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jiangsu Gian Technology Co Ltd
SHE:300709
0.202x
Bombay Burmah Trading Corporation Limited
NSE:BBTC
0.039x
Suzhou Huaya Intelligence Technology Co Ltd
SHE:003043
0.014x
Wuhan LinControl Automotive Electronics Co. Ltd. A
SHG:688667
0.053x
Hunan Keli Motor Co Ltd
SHE:002892
0.042x
Sichuan Yimikang Environmental Tech Co Ltd
SHE:300249
0.051x
Medplus Health Services Limited
NSE:MEDPLUS
0.062x
Sixt SE
XETRA:SIX3
0.081x

Annual Cash Flow Conversion Efficiency for Phibro Animal Health Corporation (2000–2025)

The table below shows the annual cash flow conversion efficiency of Phibro Animal Health Corporation from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Phibro Animal Health Corporation market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $285.68 Million $80.12 Million 0.280x -17.83%
2024-06-30 $256.64 Million $87.59 Million 0.341x +624.44%
2023-06-30 $282.51 Million $13.31 Million 0.047x -60.93%
2022-06-30 $262.44 Million $31.65 Million 0.121x -40.45%
2021-06-30 $238.53 Million $48.31 Million 0.203x -35.78%
2020-06-30 $188.20 Million $59.35 Million 0.315x +44.41%
2019-06-30 $216.01 Million $47.17 Million 0.218x -42.31%
2018-06-30 $184.95 Million $70.01 Million 0.379x -41.85%
2017-06-30 $151.16 Million $98.40 Million 0.651x +58.26%
2016-06-30 $90.48 Million $37.22 Million 0.411x -82.26%
2015-06-30 $29.63 Million $68.70 Million 2.319x +5033.82%
2014-06-30 $15.15 Million $-712.00K -0.047x -680.74%
2013-06-30 $-68.94 Million $415.00K -0.006x +98.34%
2012-06-30 $-88.23 Million $31.99 Million -0.363x +51.24%
2009-06-30 $-53.88 Million $40.06 Million -0.744x -1483.27%
2007-06-30 $-88.00 Million $-4.73 Million 0.054x +655.42%
2006-06-30 $-83.70 Million $810.00K -0.010x -107.05%
2005-06-30 $-44.90 Million $-6.16 Million 0.137x +406.05%
2004-06-30 $-63.80 Million $2.86 Million -0.045x +89.06%
2003-06-30 $-84.60 Million $34.66 Million -0.410x -627.86%
2002-06-30 $-61.20 Million $-4.75 Million 0.078x -97.99%
2001-06-30 $3.40 Million $13.14 Million 3.865x +1648.81%
2000-06-30 $31.70 Million $-7.91 Million -0.250x --

About Phibro Animal Health Corporation

NASDAQ:PAHC USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.13 Billion
Market Cap Rank
#8579 Global
#2331 in USA
Share Price
$54.89
Change (1 day)
+3.22%
52-Week Range
$19.04 - $59.58
All Time High
$59.58
About

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more